Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/36488
Full metadata record
DC FieldValueLanguage
dc.contributor.authorYardley, D A
dc.contributor.authorColeman, R
dc.contributor.authorConte, P
dc.contributor.authorCortes, J
dc.contributor.authorBrufsky, A
dc.contributor.authorShtivelband, M
dc.contributor.authorYoung, R
dc.contributor.authorBengala, C
dc.contributor.authorAli, H
dc.contributor.authorEakel, J
dc.contributor.authorSchneeweiss, A
dc.contributor.authorde la Cruz-Merino, L
dc.contributor.authorWilks, S
dc.contributor.authorO'Shaughnessy, J
dc.contributor.authorGlück, S
dc.contributor.authorLi, H
dc.contributor.authorMiller, J
dc.contributor.authorBarton, D
dc.contributor.authorHarbeck, N
dc.date.accessioned2019-06-28T18:14:51Z-
dc.date.available2019-06-28T18:14:51Z-
dc.date.issued2018-08-01
dc.identifier.citationAnn. Oncol..2018 Aug;(29)8:1763-1770
dc.identifier.urihttps://hdl.handle.net/20.500.12530/36488-
dc.description.abstractMetastatic triple-negative breast cancer (mTNBC) has a poor prognosis and aggressive clinical course. tnAcity evaluated the efficacy and safety of first-line nab-paclitaxel plus carboplatin (nab-P/C), nab-paclitaxel plus gemcitabine (nab-P/G), and gemcitabine plus carboplatin (G/C) in patients with mTNBC.
dc.language.isoeng
dc.rightsopenAccess-
dc.titlenab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from the tnAcity trial.
dc.typeArtículo
dc.identifier.pubmedID29878040
dc.format.volume29
dc.format.page1763-1770
dc.identifier.e-issn1569-8041
dc.identifier.journalAnnals of oncology : official journal of the European Society for Medical Oncology
dc.identifier.doi10.1093/annonc/mdy201
dc.format.number8
dc.identifier.pmcPMC6096741
dc.pubmedtypeJournal Article
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. Ramón y Cajal > Artículos

Files in This Item:
File Description SizeFormat 
PMC6096741.pdf253.41 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.